Tuesday - October 27, 2026
OHSU enrolls first West Coast participant in gene-editing trial for high cholesterol
September 29, 2026
PORTLAND, Oregon, Sept. 29 -- Oregon Health and Science University issued the following news:

* * *

OHSU enrolls first West Coast participant in gene-editing trial for high cholesterol

*

Oregon Health & Science University has enrolled the first participant on the West Coast in a clinical trial using gene editing to reduce a form of high cholesterol known to raise the risk of heart attack and stroke.

The multicenter, open-label . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products